COM:VIFORPHARMA
CSL Vifor
- Stock
Last Close
165.35
22/12 16:31
Volume Today
21.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 346.84M - | 364.48M 5.09% | 379.81M 4.21% | 408.15M 7.46% | 332.20M 18.61% | 256.80M 22.70% | 315.15M 22.72% | 344.20M 9.22% | 343.40M 0.23% | |
average payables | 339.96M - | 344.45M 1.32% | 355.58M 3.23% | 404.08M 13.64% | 308.93M 23.55% | 165.30M 46.49% | 132.15M 20.05% | 135M 2.16% | 162.60M 20.44% | |
average receivables | ||||||||||
book value per share | 23.24 - | 26.43 13.74% | 29.00 9.71% | 32.80 13.10% | 47.42 44.56% | 47.07 0.74% | 51.15 8.68% | 55.03 7.59% | 53.80 2.24% | |
capex per share | -1.11 - | -1.08 2.36% | -2.54 135.83% | -4.37 71.81% | -1.36 68.80% | -4.26 212.03% | -2.10 50.66% | -5.93 182.36% | -3.37 43.14% | |
capex to depreciation | -0.95 - | -0.91 3.59% | -1.90 108.73% | -2.22 16.58% | -0.61 72.72% | -1.68 177.78% | -0.63 62.33% | -1.35 113.47% | -0.68 49.45% | |
capex to operating cash flow | -0.22 - | -0.20 9.73% | -0.32 60.74% | -1.10 247.75% | -1.47 33.52% | -1.42 2.86% | -0.26 81.78% | -0.91 249.68% | -0.41 54.31% | |
capex to revenue | -0.02 - | -0.02 4.00% | -0.04 112.54% | -0.07 58.11% | -0.07 4.20% | -0.17 164.42% | -0.07 58.35% | -0.23 210.82% | -0.12 46.84% | |
cash per share | 3.33 - | 3.68 10.49% | 6.52 77.06% | 2.83 56.65% | 6.58 132.89% | 6.21 5.66% | 8.40 35.29% | 11.32 34.77% | 15.32 35.29% | |
days of inventory on hand | 59.41 - | 62.99 6.03% | 60.12 4.56% | 63.68 5.92% | 163.44 156.65% | 158.50 3.02% | 167.09 5.42% | 176.88 5.86% | 188.53 6.59% | |
days payables outstanding | 57.57 - | 58.10 0.92% | 57.09 1.73% | 65.32 14.41% | 122.77 87.94% | 88.00 28.32% | 51.72 41.23% | 84.38 63.15% | 88.61 5.02% | |
days sales outstanding | ||||||||||
debt to assets | 0.49 - | 0.45 7.90% | 0.46 0.60% | 0.58 26.09% | 0.19 66.64% | 0.25 30.82% | 0.24 3.41% | 0.23 5.71% | 0.22 3.25% | |
debt to equity | 1.01 - | 0.85 15.34% | 0.89 4.00% | 1.47 66.43% | 0.26 82.48% | 0.37 43.52% | 0.36 2.46% | 0.33 7.44% | 0.32 3.16% | |
dividend yield | 0.02 - | 0.03 58.56% | 0.01 60.20% | 0.02 55.94% | 0.02 2.46% | 0.03 56.95% | 0.02 39.46% | 0.02 59.74% | 0.02 25.96% | |
earnings yield | 0.06 - | 0.06 5.66% | 0.04 40.34% | 0.04 19.92% | 0.02 64.79% | 0.04 130.15% | 0.02 32.24% | 0.03 10.32% | 0.03 4.31% | |
enterprise value | 6.27B - | 5.53B 11.79% | 10.41B 88.29% | 9.24B 11.18% | 7.87B 14.90% | 7.10B 9.79% | 11.53B 62.45% | 8.90B 22.84% | 10.12B 13.74% | |
enterprise value over ebitda | 14.50 - | 12.81 11.63% | 22.22 73.38% | 22.35 0.59% | 5.96 73.33% | 20.38 241.85% | 27.51 35.04% | 13.10 52.37% | 19.47 48.59% | |
ev to operating cash flow | 19.04 - | 15.53 18.43% | 19.93 28.30% | 35.84 79.84% | 130.47 263.97% | 36.62 71.93% | 21.97 40.01% | 20.99 4.45% | 19.18 8.60% | |
ev to sales | 1.87 - | 1.62 13.26% | 2.75 69.65% | 2.24 18.23% | 5.86 161.15% | 4.48 23.60% | 6.14 37.12% | 5.22 15.07% | 5.55 6.32% | |
free cash flow per share | 3.97 - | 4.41 11.09% | 5.51 24.93% | -0.39 107.07% | -0.43 11.14% | -1.27 192.35% | 5.99 572.67% | 0.60 89.91% | 4.76 687.50% | |
free cash flow yield | 0.04 - | 0.06 25.96% | 0.04 37.14% | -0.00 109.69% | -0.00 2.24% | -0.01 241.58% | 0.03 386.04% | 0.00 87.18% | 0.03 574.65% | |
graham net net | -17.31 - | -15.92 8.04% | -16.20 1.73% | -42.17 160.34% | -3.87 90.82% | -9.06 134.01% | -7.40 18.32% | -4.47 39.60% | 0.56 112.63% | |
graham number | 51.99 - | 53.52 2.95% | 61.04 14.05% | 60.74 0.50% | 45.18 25.62% | 63.17 39.83% | 69.69 10.31% | 67.35 3.36% | 70.38 4.50% | |
income quality | 1.11 - | 1.25 12.60% | 1.73 38.65% | 1.06 38.97% | 0.05 95.03% | 1.27 2,319.09% | 3.30 159.39% | 1.18 64.27% | 3.65 209.91% | |
intangibles to total assets | 0.41 - | 0.40 2.50% | 0.44 9.81% | 0.63 42.41% | 0.64 2.55% | 0.60 7.35% | 0.52 12.01% | 0.47 10.08% | 0.47 0.66% | |
interest coverage | 11.17 - | 14.19 27.02% | 17.51 23.36% | 9.33 46.72% | 46.58 399.42% | 27.09 41.85% | 22.67 16.32% | 51.22 125.97% | 22.19 56.68% | |
interest debt per share | 10.75 - | 10.20 5.03% | 10.09 1.13% | 31.10 208.23% | 3.43 88.96% | 8.81 156.63% | 9.64 9.32% | 9.51 1.27% | 9.19 3.40% | |
inventory turnover | 6.14 - | 5.79 5.68% | 6.07 4.77% | 5.73 5.59% | 2.23 61.04% | 2.30 3.11% | 2.18 5.14% | 2.06 5.53% | 1.94 6.18% | |
invested capital | 0.44 - | 0.37 15.81% | 0.34 9.47% | 0.93 177.65% | 0.06 93.12% | 0.19 188.09% | 0.19 0.34% | 0.17 8.06% | 0.17 1.45% | |
market cap | 5.82B - | 5.13B 11.82% | 10.20B 98.79% | 7.44B 27.03% | 8.09B 8.78% | 6.93B 14.36% | 11.46B 65.28% | 9.02B 21.31% | 10.52B 16.73% | |
net current asset value | -310.89M - | -155.60M 49.95% | -242.12M 55.61% | -1.74B 619.38% | 300.10M 117.23% | 117.90M 60.71% | 208.10M 76.51% | 414.90M 99.38% | 748.10M 80.31% | |
net debt to ebitda | 1.04 - | 0.92 11.25% | 0.45 51.42% | 4.36 873.54% | -0.17 103.96% | 0.47 373.77% | 0.17 64.07% | -0.18 204.70% | -0.78 340.34% | |
net income per share | 5.17 - | 4.82 6.81% | 5.71 18.57% | 5.00 12.46% | 1.91 61.73% | 3.77 96.98% | 4.22 11.97% | 3.66 13.20% | 4.09 11.70% | |
operating cash flow per share | 5.08 - | 5.49 8.16% | 8.06 46.71% | 3.98 50.59% | 0.93 76.63% | 2.99 221.20% | 8.09 170.75% | 6.53 19.25% | 8.13 24.45% | |
payables turnover | 6.34 - | 6.28 0.91% | 6.39 1.76% | 5.59 12.60% | 2.97 46.79% | 4.15 39.51% | 7.06 70.15% | 4.33 38.71% | 4.12 4.78% | |
receivables turnover | ||||||||||
research and ddevelopement to revenue | 0.14 - | 0.13 5.56% | 0.12 6.63% | 0.15 20.54% | 0.14 5.51% | |||||
return on tangible assets | 0.19 - | 0.16 12.39% | 0.18 11.86% | 0.16 12.06% | 0.08 47.33% | 0.13 59.78% | 0.12 13.29% | 0.09 26.01% | 0.10 13.49% | |
revenue per share | 51.85 - | 52.74 1.71% | 58.52 10.96% | 63.59 8.66% | 20.71 67.43% | 24.44 18.01% | 28.95 18.45% | 26.29 9.16% | 28.13 6.98% | |
roe | 0.22 - | 0.18 18.07% | 0.20 8.07% | 0.15 22.60% | 0.04 73.52% | 0.08 98.45% | 0.08 3.03% | 0.07 19.32% | 0.08 14.26% | |
roic | 0.14 - | 0.13 9.23% | 0.14 4.29% | 0.06 55.95% | 0.37 526.24% | 0.05 87.36% | 0.05 2.20% | 0.10 104.35% | 0.06 41.54% | |
sales general and administrative to revenue | 0.02 - | 0.02 2.94% | 0.02 11.57% | 0.03 38.71% | 0.12 366.68% | 0.10 18.70% | 0.08 21.11% | 0.09 17.63% | 0.08 13.13% | |
shareholders equity per share | 23.24 - | 26.43 13.74% | 29.00 9.71% | 32.80 13.10% | 47.42 44.56% | 47.07 0.74% | 51.15 8.68% | 55.03 7.59% | 53.80 2.24% | |
stock based compensation to revenue | ||||||||||
tangible asset value | 293.84M - | 465.05M 58.27% | 374.75M 19.42% | -1.10B 394.09% | 681.50M 161.84% | 688.50M 1.03% | 1.15B 67.15% | 1.56B 35.82% | 1.58B 1.29% | |
tangible book value per share | 4.54 - | 7.18 58.29% | 5.78 19.44% | -17.02 394.21% | 10.52 161.80% | 10.62 0.97% | 17.74 67.12% | 24.10 35.81% | 24.41 1.29% | |
working capital | 453.23M - | 617.60M 36.26% | 617.81M 0.04% | -1.25B 302.09% | 504.60M 140.41% | 654.40M 29.69% | 865.80M 32.30% | 1.06B 23.01% | 897.30M 15.75% |
All numbers in (except ratios and percentages)